CE认证
皮肤填充剂
Yvoire Y-Solution 360 is a cross-linked hyaluronic acid dermal filler manufactured in South Korea as part of the YVOIRE Y-Solution range, which is built on a synergy between elasticity and cohesion that gives the gel spring-like characteristics for flexibility, projection and resistance to the dynamics of facial expression. The Y-Solution numbers are lift tiers rather than concentrations, and the 360 is the lightest gel in the entire Yvoire range. The product contains cross-linked hyaluronic acid at 12 mg/mL (1.2%) with 0.3% lidocaine and is intended for professional use by qualified practitioners only. It is supplied as a single 1 mL syringe with two Terumo thin-wall 29G needles enclosed; its shelf life is 17 months, shorter than the 24 months of the Classic, Volume and Contour references, so check the date when rotating stock.
主要优势： Yvoire Y-Solution 360
- Combines elasticity and cohesion, which the manufacturer describes as spring-like characteristics
- Provides flexible projection and is designed to resist the dynamics of facial expression
- Cross-linked hyaluronic acid at 12 mg/mL with 0.3% lidocaine, the lightest gel in the Yvoire range
- Built on the manufacturer's S-HICE cross-linking process
- Supports anti-ageing aesthetic treatment approaches
- Part of the Y-Solution 360, 540 and 720 range, where the number is a lift tier rather than a concentration
- Supplied with two Terumo thin-wall 29G needles
适应症与专业用途
主要适应症
- Anti-ageing aesthetic treatment
- Facial projection support
- Treatments requiring flexibility and cohesion
专业用途
Yvoire Y-Solution 360 is intended for administration by qualified medical practitioners trained in dermal filler injection technique, using aseptic technique. The manufacturer gives the application zone as the face and the injection site as the facial skin layer, and encloses two Terumo thin-wall 29G needles, a notably fine gauge that reflects a lighter gel than the Volume and Contour references in the range. This reference contains 0.3% lidocaine, so patients must be screened for sensitivity to amide-type local anaesthetics before treatment. Injection technique and volume per treatment area are determined by the practitioner.
治疗部位
- Face
适用患者
Suitable for adult patients seeking anti-ageing correction where flexibility and resistance to facial movement matter, as assessed by a qualified practitioner. At 12 mg/mL this is the lightest gel in the whole Yvoire range, well below the 20 to 22 mg/mL of the Volume and Contour references, so patients seeking structural contouring of the chin or nose, or correction of deep folds, are better served by those products. Because this reference contains an amide-type local anaesthetic, patients with known lidocaine sensitivity are not candidates.
作用原理： Yvoire Y-Solution 360
Yvoire Y-Solution 360 works through cross-linked hyaluronic acid at 12 mg/mL (1.2%), made by the manufacturer's S-HICE process and formulated for what it describes as a synergy between elasticity and cohesion. The intended effect is spring-like: the gel flexes with the face rather than resisting it, which is why the range is positioned around projection that survives the dynamics of facial expression rather than around static filling. At 12 mg/mL this is the lightest gel in the Yvoire range, against 20 to 22 mg/mL for the Volume and Contour references, and the two Terumo thin-wall 29G needles enclosed reflect that. The 0.3% lidocaine acts locally to improve comfort during injection.
为什么选择在 Allpara 订购
Allpara 提供正品、经过验证的 YVOIRE 产品，来自经过严格审核的供应商，具备完整的批次可追溯性和专家支持。我们为诊所和医美专业人士提供CE认证产品、从欧盟仓库快速配送至欧盟各地，以及具有竞争力的专业价格。我们关注的是您患者的安全、满意度和效果，并提供专属售后支持，让您安心无忧。
常见问题
What is in Yvoire Y-Solution 360?
Cross-linked hyaluronic acid at 12 mg/mL (1.2%) with 0.3% lidocaine. Patients should be screened for sensitivity to amide-type local anaesthetics beforehand.
How does Yvoire Y-Solution 360 differ from Yvoire Y-Solution 540 and Yvoire Y-Solution 720?
Yvoire Y-Solution 360 is 12 mg/mL with 29G needles. Yvoire Y-Solution 540 and Yvoire Y-Solution 720 both state 20 mg/mL with 0.3% lidocaine and two 27G needles, and are positioned at different lift levels rather than different concentrations. All three share the same elasticity and cohesion concept, and the numbers are lift tiers rather than concentrations.
更多产品： LG Chem
诊所替代选择
美塑疗法
水光针
/ 最近浏览
继续浏览
Yvoire Y-Solution 360 is a cross-linked hyaluronic acid dermal filler manufactured in South Korea as part of the YVOIRE Y-Solution range, which is built on a synergy between elasticity and cohesion that gives the gel spring-like characteristics for flexibility, projection and resistance to the dynamics of facial expression. The Y-Solution numbers are lift tiers rather than concentrations, and the 360 is the lightest gel in the entire Yvoire range. The product contains cross-linked hyaluronic acid at 12 mg/mL (1.2%) with 0.3% lidocaine and is intended for professional use by qualified practitioners only. It is supplied as a single 1 mL syringe with two Terumo thin-wall 29G needles enclosed; its shelf life is 17 months, shorter than the 24 months of the Classic, Volume and Contour references, so check the date when rotating stock.
主要优势： Yvoire Y-Solution 360
- Combines elasticity and cohesion, which the manufacturer describes as spring-like characteristics
- Provides flexible projection and is designed to resist the dynamics of facial expression
- Cross-linked hyaluronic acid at 12 mg/mL with 0.3% lidocaine, the lightest gel in the Yvoire range
- Built on the manufacturer's S-HICE cross-linking process
- Supports anti-ageing aesthetic treatment approaches
- Part of the Y-Solution 360, 540 and 720 range, where the number is a lift tier rather than a concentration
- Supplied with two Terumo thin-wall 29G needles
适应症与专业用途
主要适应症
- Anti-ageing aesthetic treatment
- Facial projection support
- Treatments requiring flexibility and cohesion
专业用途
Yvoire Y-Solution 360 is intended for administration by qualified medical practitioners trained in dermal filler injection technique, using aseptic technique. The manufacturer gives the application zone as the face and the injection site as the facial skin layer, and encloses two Terumo thin-wall 29G needles, a notably fine gauge that reflects a lighter gel than the Volume and Contour references in the range. This reference contains 0.3% lidocaine, so patients must be screened for sensitivity to amide-type local anaesthetics before treatment. Injection technique and volume per treatment area are determined by the practitioner.
治疗部位
- Face
适用患者
Suitable for adult patients seeking anti-ageing correction where flexibility and resistance to facial movement matter, as assessed by a qualified practitioner. At 12 mg/mL this is the lightest gel in the whole Yvoire range, well below the 20 to 22 mg/mL of the Volume and Contour references, so patients seeking structural contouring of the chin or nose, or correction of deep folds, are better served by those products. Because this reference contains an amide-type local anaesthetic, patients with known lidocaine sensitivity are not candidates.
作用原理： Yvoire Y-Solution 360
Yvoire Y-Solution 360 works through cross-linked hyaluronic acid at 12 mg/mL (1.2%), made by the manufacturer's S-HICE process and formulated for what it describes as a synergy between elasticity and cohesion. The intended effect is spring-like: the gel flexes with the face rather than resisting it, which is why the range is positioned around projection that survives the dynamics of facial expression rather than around static filling. At 12 mg/mL this is the lightest gel in the Yvoire range, against 20 to 22 mg/mL for the Volume and Contour references, and the two Terumo thin-wall 29G needles enclosed reflect that. The 0.3% lidocaine acts locally to improve comfort during injection.
为什么选择在 Allpara 订购
Allpara 提供正品、经过验证的 YVOIRE 产品，具备完整的批次可追溯性、CE认证库存、欧盟范围内快速配送以及专业的售后支持。
常见问题
What is in Yvoire Y-Solution 360?
Cross-linked hyaluronic acid at 12 mg/mL (1.2%) with 0.3% lidocaine. Patients should be screened for sensitivity to amide-type local anaesthetics beforehand.
How does Yvoire Y-Solution 360 differ from Yvoire Y-Solution 540 and Yvoire Y-Solution 720?
Yvoire Y-Solution 360 is 12 mg/mL with 29G needles. Yvoire Y-Solution 540 and Yvoire Y-Solution 720 both state 20 mg/mL with 0.3% lidocaine and two 27G needles, and are positioned at different lift levels rather than different concentrations. All three share the same elasticity and cohesion concept, and the numbers are lift tiers rather than concentrations.
更多产品： LG Chem
查看制造商 →* 专业用途产品。包装可能因批次或市场而异。完整的使用说明和禁忌症请参阅随附的使用说明书。